Seres Therapeutics MCRB
NASDAQ MCRB
$2.33 +0.02 (+0.87%)
As of: Oct 21, 2026 · 3:39 PM EDT

Seres Therapeutics (MCRB) Restructuring Costs (2019)

Updated

Seres Therapeutics' Restructuring Costs was $1.49 million in FY2019.

Analysis

Seres Therapeutics (MCRB) Restructuring Costs (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,138.33 Bn 1,106.91 Bn 19.71 Bn
2 Johnson & Johnson 618.82 Bn 537.35 Bn 17.26 Bn
3 AbbVie 503.36 Bn 476.47 Bn 12.70 Bn
4 Merck 369.59 Bn 323.96 Bn 12.21 Bn
5 Novartis Ag 298.57 Bn 262.56 Bn 11.24 Bn
6 Astrazeneca 261.25 Bn 234.94 Bn 12.86 Bn
7 Amgen 237.35 Bn 192.75 Bn 7.24 Bn
8 Gilead Sciences 191.27 Bn 165.47 Bn 6.22 Bn
9 Pfizer 170.03 Bn 116.68 Bn 10.94 Bn
10 Seres Therapeutics 22.62 Mn -116.22 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 1.49 Mn
API Access

Seres Therapeutics Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=MCRB&period=max&api_key=YOUR_API_KEY